Skip to content

Assessing the Utility of Phototherapy Rompers in Kangaroo Mother Care, Feeding, and Natural Care Tasks

Evaluation of a photo therapy rompers utility during kangaroo mother care, feeding, and other natural care tasks. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060348
Enrollment
10
Registered
2023-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P599- Neonatal jaundice, unspecified

Interventions

Intervention1: Phototherapy Romper: Phototherapy Romper is a wearable phototherapy device and is a natural care device. It emits blue LED light in the spectral bandwidth of 460 to 480 nm and helps to

Sponsors

Dr R Lakshmipathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newborns at or above 35 weeks gestation with the pre discharge TSB level placing the newborn in high intermediate and low intermediate risk zone parents or legal guardian who provide informed consent for their baby participation in the study the parents of the neonate are able to provide kangaroo mother care and fee the baby as per instructions of the neonatologists

Exclusion criteria

Exclusion criteria: Newborns below 35 weeks gestation Newborns with contraindications to phototherapy Newborns with co morbidities other than hyperbilirubinemia Parents or legal guardians who do not provide informed consent for their baby participation in the study

Design outcomes

Primary

MeasureTime frame
Usability assessment and user friendliness particularly during the kangaroo mother care and feedingTimepoint: During and end of study

Secondary

MeasureTime frame
Incidence of adverse events related to the use of the phototherapy romper Other study parametersTimepoint: Baseline and End of study;?Adherence to using the phototherapy romper during kangaroo mother care and feeding periods.Timepoint: End of study;?Duration of phototherapy required to achieve clinically acceptable bilirubin levels for stopping phototherapy.Timepoint: End of study

Countries

India

Contacts

Public ContactDr R Lakshmipathy

North Bengalore Hospital

lakshmipathy_r@yahoo.co.in9741895201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026